As of 2024-09-14, the Relative Valuation of Blueprint Medicines Corp (BPMC) is (84.17) USD. This relative valuation is based on P/E multiples. With the latest stock price at 88.90 USD, the upside of Blueprint Medicines Corp based on Relative Valuation is -194.7%.
The range of the Relative Valuation is (79.79) - (77.39) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.6x - 42.2x | 29.4x |
| Forward P/E multiples | 19.1x - 23.9x | 22.5x |
| Fair Price | (79.79) - (77.39) | (84.17) |
| Upside | -189.8% - -187.1% | -194.7% |
| Date | P/E |
| 2024-09-13 | -27.41 |
| 2024-09-12 | -25.93 |
| 2024-09-11 | -26.69 |
| 2024-09-10 | -26.51 |
| 2024-09-09 | -26.68 |
| 2024-09-06 | -26.65 |
| 2024-09-05 | -28.18 |
| 2024-09-04 | -28.55 |
| 2024-09-03 | -28.53 |
| 2024-08-30 | -29.46 |
| 2024-08-29 | -28.86 |
| 2024-08-28 | -28.60 |
| 2024-08-27 | -28.72 |
| 2024-08-26 | -29.31 |
| 2024-08-23 | -29.15 |
| 2024-08-22 | -28.83 |
| 2024-08-21 | -29.22 |
| 2024-08-20 | -28.73 |
| 2024-08-19 | -29.51 |
| 2024-08-16 | -28.82 |
| 2024-08-15 | -29.45 |
| 2024-08-14 | -28.78 |
| 2024-08-13 | -28.62 |
| 2024-08-12 | -28.89 |
| 2024-08-09 | -28.95 |
| 2024-08-08 | -28.19 |
| 2024-08-07 | -28.01 |
| 2024-08-06 | -28.59 |
| 2024-08-05 | -28.66 |
| 2024-08-02 | -29.82 |
| 2024-08-01 | -30.92 |
| 2024-07-31 | -33.39 |
| 2024-07-30 | -33.00 |
| 2024-07-29 | -34.02 |
| 2024-07-26 | -34.59 |
| 2024-07-25 | -35.05 |
| 2024-07-24 | -35.45 |
| 2024-07-23 | -36.06 |
| 2024-07-22 | -36.01 |
| 2024-07-19 | -35.45 |
| 2024-07-18 | -34.98 |
| 2024-07-17 | -35.26 |
| 2024-07-16 | -37.15 |
| 2024-07-15 | -36.85 |
| 2024-07-12 | -36.31 |
| 2024-07-11 | -36.32 |
| 2024-07-10 | -35.75 |
| 2024-07-09 | -35.53 |
| 2024-07-08 | -35.86 |
| 2024-07-05 | -34.44 |